ZDHHC12 Inhibitors

ZDHHC12 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the enzyme ZDHHC12, a member of the DHHC family of protein palmitoyltransferases. ZDHHC12 catalyzes the post-translational modification known as S-palmitoylation, which involves the attachment of a palmitoyl group, a fatty acid, to cysteine residues on target proteins. This modification plays a crucial role in regulating the localization, trafficking, stability, and function of various proteins by enhancing their membrane association. The enzymatic activity of ZDHHC12 is mediated by its DHHC (Asp-His-His-Cys) domain, which is essential for the transfer of the palmitoyl group from palmitoyl-CoA to substrate proteins. Inhibitors of ZDHHC12 interfere with this catalytic process, preventing the palmitoylation of target proteins, which alters their membrane dynamics and cellular functions.

Mechanistically, ZDHHC12 inhibitors can function in several ways. One common approach is the competitive inhibition of the enzyme's active site by mimicking the structure of palmitoyl-CoA, the natural substrate for the palmitoylation reaction. By occupying the active site, these inhibitors block the access of palmitoyl-CoA, thereby preventing the enzyme from catalyzing the transfer of the palmitoyl group to substrate proteins. Another approach involves targeting the DHHC domain, particularly the catalytic cysteine residue, which is crucial for the enzymatic activity. Some inhibitors may bind directly to this site, rendering the enzyme inactive by preventing the necessary catalytic reactions. By inhibiting ZDHHC12, these compounds affect the palmitoylation-dependent localization and function of numerous proteins, providing insights into how protein palmitoylation influences cellular processes such as signaling, trafficking, and protein-protein interactions. The study of ZDHHC12 inhibitors is critical for understanding the broader role of protein palmitoylation in cellular regulation.